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ABSTRACT 
Chronic lung disease, bronchopulmonary dysplasia (BPD) is a common and severe 
complication among extremely preterm born infants and infants with lung hypoplasia. 
Clinical grading of BPD is performed at 36 weeks postmenstrual age (or 56 days of age in 
moderately preterm infants) based on the need for supplemental oxygen. Oxygen requirement 
is a poor predictor for lung function in childhood and at adult age. We aimed to evaluate a 
lung function measurement for infants and children with BPD to complement clinical 
grading, evaluate the impact of respiratory management and standardize follow-up. 
No functional imaging of the lung in neonatal patients has been reported earlier. Single 
photon emission computed tomography (SPECT) is a technique that gives a functional 
imaging at a regional level within the lung. Previously the technique has not been available to 
use in non-cooperating patients that are small in body size. Recent technical advances and the 
development of a system for inhalation by our research group opened up the possibility of 
applying SPECT in neonatal patients. Our aim was to see if three different groups of patients, 
extremely/very preterm born infants, children with BPD or infants with congenital 
diaphragmatic hernia and lung hypoplasia, had lung function impairment with ventilation 
perfusion abnormalities within the lung. 
In paper I and IV we compare ventilation (V) perfusion (Q) matching with clinical severity 
grading, clinical characteristics and respiratory support during the first week of life (paper IV) 
and for the whole stay in the neonatal unit (paper I). V/Q abnormalities were correlated with 
BPD severity grade. Increasing days with mechanical ventilation (MV) were negatively 
correlated with lung function measured by SPECT. Higher values of carbon dioxide on the 
first day of life and during the first week were associated with better V/Q matching. High 
mean airway pressure (MAP) day 1 of life, a large decrease in MAP and early weaning of 
mechanical ventilation were also associated with better V/Q matching. High MAP and 
oxygen demand at day seven of life were associated with an increased severity grade of BPD. 
Additionally we found that one third of the patients graded as Mild or Moderate BPD had 
widespread V/Q abnormalities. 
In paper II we studied patients with lung hypoplasia and congenital diaphragmatic hernia. In 
this group, V/Q abnormalities were also associated with increasing days with MV but also 
increasing days with extracorporeal membrane oxygenation and persistence of pulmonary 
hypertension.  
In a follow-up study of 10-year-old children with BPD born preterm (paper III), we found 
less V/Q abnormalities than in the preterm infants but lower values of lung volume with good 
V/Q matching than expected in lung healthy children at that age.  
SPECT can be used as a measurement of lung function and evaluation of treatment in 
neonatal patients, infants and children and as a compliment to clinical grading and for follow-
up of lung function in survivors with BPD. Ventilation perfusion matching abnormalities are 
common among patients with BPD both in the newborn period and at school age.   
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1. BACKGROUND 
1.1 SURVIVAL AT THE LIMIT OF VIABILITY  
Survival of infants born at the limits of viability has steadily increased in the last decades. 
Sweden has been in the front-line of management of these infants for many years. About 30 
years ago only 25% of infants born at 24 weeks gestational age survived while this figure 
today is approaching 80% 1. In infants born today before 25 week gestational age about 75% 
will require supplemental oxygen at 36 weeks postmenstrual age 2. After improvement in 
preoperative management for infants with congenital diaphragmatic hernia the survival rate 
has increased to 85% in Stockholm compared to 69% internationally 3. Also patients with 
severe lung hypoplasia can now survive. What impact extreme preterm birth and severe lung 
hypoplasia have on future pulmonary function in these children is unknown.  
Figure 1. Neonatal survival rate 1985-2016 in Sweden 1  
 
Reprinted with the permission of Copyright © 2018, American Academy of Pediatrics. 
Neonatal survival 1985 and 2016 in Sweden of live-born infants at a gestational age of 22 to 
26 completed weeks. 
  
Neonatal survival of extremely preterm, live-born infants at 22 to 26 completed weeks’ gestation 
in Sweden between 1985 and 2016 by gestational age and year of birth. 
Magnus Domellöf, and Baldvin Jonsson Pediatrics 
2018;142:S533-S538 
©2018 by American Academy of Pediatrics 
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1.2 NORMAL DEVELOPMENT OF THE LUNG 
Alveolarization of the lung starts at around 32 weeks gestational age and continues until the 
age of two years. There is some evidence that it can continue to some extent even after this 
period 4,5. Extremely preterm infants are born before alveolarization has started at a time 
point when the lung is very vulnerable to injury. Prenatal and postnatal exposures to 
potentially harmful factors can lead to an arrested development or structural damage within 
the lung.  
Figure 2. Stages of lung development, risk factors, and types of lung injury 6 
 
Copyright © 2007 Massachusetts Medical Society. Reprinted with permission from 
Massachusetts Medical Society. Baraldi E, Filippone M. N Engl J Med 2007;357:1946-1955. 
In infants with congenital diaphragmatic hernia the mechanism leading to a reduced lung 
function is different. Congenital diaphragmatic hernia (CDH) is a developmental defect 
occurring in 2,3 per 10 000 births with a survival rate of about 70% the first week of life 7. 
The diaphragmatic defect is usually posterolateral (Bochdalek hernia), but may be anterior 
retrosternal or parasternal (Morgagni hernia), or rarely central. 
 CDH is associated with lung hypoplasia on the same side as the hernia (ipsilateral) but the 
lung on the other side (contralateral) can also be affected. Bronchial and pulmonary arterial 
branching is reduced in utero due to compression from the hernia on the ipsilateral lung and if 
there is a mediastinal shift also the contralateral lung. Reduced arterial branching results in 
muscular hyperplasia of the pulmonary arterial tree, which contributes to increased risk of 
persistent pulmonary hypertension of the newborn 8. The pulmonary vascular bed in CDH 
patients is not only reduced in size but also responds abnormally to vasodilators with an 
increased sensitivity in all pulmonary vessels 9. Severe pulmonary hypoplasia and persistence 
of pulmonary hypertension are the biggest risk factors for an adverse outcome 10,11. McGoon 
index is the combined diameter of the right and left pulmonary arteries compared to the 
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descending aorta. In infants with congenital diaphragmatic hernia a modified McGoon index 
has been used. A cutoff value of 1.25-1.3 predicted mortality with 73-85% sensitivity 12,13. 
Figure 3. Left sided congenital diaphragmatic hernia compressing ipsilateral and 
contralateral lung 
 
Copyright © Nucleus Medical Media, Inc. Reprinted with permission. 
 
1.3 BRONCHOPULMONARY DYSPLASIA 
Bronchopulmonary dysplasia (BPD) remains a common and sometimes severe complication 
in extremely preterm born children and infants with underlying pulmonary abnormalities 14,15. 
Today with the progress in neonatal care for extremely preterm infants, including prenatal 
steroids, surfactant therapy and gentler mechanical ventilation and for moderately preterm 
infants treatment with inhaled nitric oxide and extra corporal membrane oxygenation, 
increasing numbers of sicker and more preterm infants survive. How we treat these children 
in the beginning can have an impact on lung function at full term age, during childhood and 
the rest of their lives.  
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1.3.1 Incidence 
In Sweden all infants born at 23 weeks gestational age will develop BPD. 16 In infants born ≤ 
25 weeks gestational age and 25-27 weeks gestational age 75% and 45% respectively will 
develop moderate or severe BPD 17. Several studies though, report airway abnormalities also 
in preterm born infant without BPD compared to term born controls 18,19.  
In infants with congenital diaphragmatic hernia the incidence of BPD is about 30%-49% in 
surviving infants 20,21.  
1.3.2 Definition of BPD 
When BPD was first described by Northway et al in 1967 the severe histopathological and 
radiographic changes formed the base for diagnosis 22. He reported atelectasis, emphysema, 
fibrosis, smooth muscle hypertrophy and widespread vascular changes within the lung in 19 
non-surviving moderately preterm infants treated with mechanical ventilation and oxygen for 
respiratory distress syndrome (RDS). He coined the term bronchopulmonary dysplasia and 
described 4 radiographic stages of BPD in these infants and in 13 infants who survived. The 
mean gestational age for survivors and non-survivors were 34 and 31 weeks respectively. 
Toce et al suggested a combined clinical and radiographic scoring system to enable 
comparison between different centers. The scoring should be performed at 21 days of age in 
infants at risk of developing BPD 23. The radiographic scoring system was a modification of 
the one suggested by Edwards 24. Clinical factors evaluated included respiratory symptoms 
like retractions, weight gain, oxygen demand and pCO2. The patients in this study had a 
mean gestational age of 30.9 and 32.6 weeks. 
In 1988 Shennan et al proposed that oxygen need at the time of discharge, around 36 weeks 
postmenstrual age, was a better marker for severity of disease than an chest X-ray 25. With 
improvement in neonatal care smaller and more preterm infants survived and developed 
respiratory impairment but without the typical radiographic and histopathological changes. 
Instead alveolarization and vascular development was arrested or delayed resulting in a 
reduced alveolar surface area 26. This is now described as New BPD 27. “Old” BPD is 
characterized by damaged lung parenchyma where atelectasis, fibrosis, inflammation and 
emphysema dominate the picture, while in “new” BPD arrested alveolar development and 
dysmorphic vascularization are the main features leading to fewer and larges alveoli and a 
reduced alveolar area. Newer research indicates the presence of precapillary arteriovenous 
anastomotic vessels in the lungs of diseased infants with severe BPD. These vessels could 
contribute to intrapulmonary shunt and hypoxemia in neonates with BPD 28. 
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Figure 4: Old versus new BPD. 6 Type of parenchymal damage. 
 
Copyright © 2007 Massachusetts Medical Society. Reprinted with permission from 
Massachusetts Medical Society. Baraldi E, Filippone M. N Engl J Med 2007;357:1946-1955. 
A further modified definition of BPD came in 2001 from a workshop at the National Institute 
of Health. The diagnosis of BPD was set if there was a sustained need for supplemental 
oxygen for 28 days or more and the severity grading was performed at 36 weeks 
postmenstrual age for infants born before 32 weeks gestational age (GA) and otherwise at 56 
days of age 29. 
1.3.3 Severity grading 
The severity grading was based on need for supplemental oxygen and/or positive pressure 
support as follows; 
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Figure 5. Diagnosis and clinical grading of BPD 29 
 
PPS: Positive pressure support, PMA: Post menstrual age 
Mild: No need for supplemental oxygen or positive pressure respiratory support to maintain 
an adequate saturation 
Moderate: Supplemental oxygen 22-30% but no need for positive pressure respiratory 
support. Oxygen reduction test can be performed. 
Severe: More than 30% oxygen and/or need for positive pressure respiratory support 
This definition has been criticized since use of supplemental oxygen differs between hospitals 
and individual families after discharge. To get a more standardized definition for research, 
follow up and comparison between centers Walsh developed the “Oxygen reduction test” 
30,31. In summary, this test, which is performed at 36 weeks postmenstrual age in patients, 
graded as Moderate BPD by the NIH definition, are defined as non-BPD if they maintain 
saturations above 90% in room air for 60 minutes and defined as BPD if they fail to do so. 
This definition reduced the incidence of BPD since Mild BPD and some infants in the group 
of Moderate BPD according to the NIH definition are now defined as non-BPD. This 
simplification may not be an optimal predictor for long-term pulmonary outcome. 
The most common definition in use today and the definition used in my research is the NIH 
definition from 2001. However, the predictive value of grading according to this definition 
has been questioned 32. A concern is that the clinical oxygen and/or positive pressure criteria 
at 36 weeks may not identify important pulmonary abnormalities that can lead to a reduced 
Supplemental oxygen >28 days 
BPD 
Grading: 
36 weeks PMA/ day 56 
Mild  21% 
22-29% 
Moderate 
 
≥30%+⁄ PPS Severe 
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lung capacity in BPD survivors 33. Sensitivity for future pulmonary morbidity is 0,27-0,67 
and positive predictive value is 0,11-0,75 in different follow-up studies 32. The Canadian 
Neonatal Network found in a recent overview that oxygen and/or respiratory support at 40 
weeks postmenstrual age (PMA) best predicted ongoing respiratory and neurosensory 
morbidity at 18-24 months of age 34. In many centers infants are discharged from hospital 
before 40 weeks PMA why an earlier time point would seem more practical. Newer 
modalities for evaluation and follow up of actual lung function and to assess regional 
ventilation and perfusion have been called for 35. An updated version of the NIH definition 
has recently been published 36. This also takes into consideration new modes of respiratory 
care such as high flow nasal cannula with room air and low flow nasal cannula with 100% 
oxygen. It also incorporates infants who die before 36 weeks PMA of pulmonary failure as 
these can be considered to have the worst form of BPD. 
Table I. Suggested refinements to the definition of BPD 36 
Grades Invasive IPPV* 
N-CPAP, 
NIPPV, or nasal 
cannula ≥ 3 
L/min 
Nasal 
cannula 
flow of 1-<3 
L/min 
Hood 
O2 
Nasal 
cannula 
flow of <1 
L/min 
I — 21 22-29 22-29 22-70 
II 21 22-29 ≥30 ≥30 >70 
III >21 ≥30    
III(A) 
Early death (between 14 days of postnatal age and 36 weeks) 
owing to persistent parenchymal lung disease and respiratory 
failure that cannot be attributable to other neonatal morbidities (eg, 
necrotizing enterocolitis, intraventricular hemorrhage, redirection 
of care, episodes of sepsis, etc). 
*Excluding infants ventilated for primary airway disease or central respiratory control 
conditions. CPAP, continuous positive airway pressure; IPPV, intermittent positive pressure 
ventilation; N-CPAP, nasal continuous positive airway pressure; NIPPV, noninvasive 
positive pressure ventilation. 
Reprinted with the permission from Elsevier 
This refinement is welcome since in the NIH definition infants with CPAP are automatically 
classified as severe BPD. In some centers CPAP might be used for extra pulmonary 
conditions such as apnea of prematurity or congenital heart disease. But even in this 
definition no functional measurement of the lung is incorporated. 
 
1.4 RISK FACTORS FOR BPD 
The pathogenesis of BPD is multifactorial and not fully comprehended. BPD represents a 
wide spectrum of pulmonary disease in preterm born infants and infants with pulmonary 
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abnormalities. The biggest risk factor is low gestational age 37 but apart from this a wide 
variety of risk factors have been identified and some others have been proposed but not 
verified. Infants with CDH or other congenital abnormalities leading to lung hypoplasia 
also have a high risk of developing BPD. Figure 6 is an overview of identified and 
suspected risk factors. 
Figure 6. Risk factors for developing BPD 36. 
 
Reprinted with the permission from Elsevier. PDA= patent duct.  
1.4.1 Respiratory support 
Several studies show a direct relationship between exposure to mechanical ventilation and an 
increased risk of developing BPD 38-42. Compared to mechanical ventilation prophylactic 
nasal CPAP in very preterm infants reduces the need for mechanical ventilation, surfactant 
and incidence of BPD and death or BPD 43. 
Early extubation to non-invasive positive pressure support after Surfactant therapy reduces 
days with mechanical ventilation (MV), days with supplemental oxygen and hospital stay in 
moderately premature infants compared to when they are exposed to prolonged MV 44. A less 
aggressive ventilatory strategy at birth with initial use of CPAP instead of mandatory 
intubation in extremely preterm infants reduced oxygen supplementation and 
moderate/severe BPD or death at 40 weeks PMA in a comparison between different centers 
45. CPAP versus intubation and surfactant in the delivery room decreases pulmonary 
morbidity at 18-22 months 17. Strategies aimed at avoiding mechanical ventilation in 
extremely preterm infants reduces rate of BPD 46. Initiation of mechanical ventilation is an 
independent risk factor for developing BPD 47. In one study mechanical ventilation on day 
seven had high sensitivity (99%) and specificity (67%) for predicting BPD and even higher 
specificity (92%) for predicting severe BPD 39. Increasing days with MV is associated with 
an increasing severity grade of BPD 37. 
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1.4.2 Oxygen toxicity 
Studies in numerous animal models have demonstrated that high levels of oxygen alone 
induce a BPD like disease with compromised alveolar development and pulmonary vascular 
remodeling 48. Even brief exposure to high levels of oxygen during resuscitation increases the 
risk for BPD in premature infants 49. However, five randomized controlled trials, including 
4800 extremely preterm infants, have shown that higher saturation targets of 91-95% versus 
lower saturation targets of 85-89% during the hospital stay reduced mortality and necrotizing 
enterocolitis before discharge but there was no difference in mortality/disability, BPD, 
neurodevelopmental outcome, hearing loss, retinopathy of prematurity at 18-24 months 50-54. 
In all five studies there was a non-significant trend for a reduction of BPD at 36 weeks in the 
low saturation group, which is expected since they could be weaned of oxygen earlier with 
lower saturation targets. According to one review the quality of evidence for these outcomes 
was moderate to low 55. In a recent review by Stenson he states that saturation targets below 
90% increase mortality and do not reduce morbidity such as ROP and BPD and can therefore 
not be recommended 56. 
1.4.3 Infection 
Several studies suggest a correlation between chorioamnionitis and BPD. A meta-analysis 
from 1996 including 59 studies and over 15,000 infants concluded that there is a limited 
association after adjustment for gestational age 57. A more recent review with VLBW infants 
born 1989-2014 arrives at the same conclusion 58. Chorioamnionitis induced lung maturation 
and increases surfactant production 59 but prenatal inflammation in the lung might make it 
more susceptible to postnatal injury. 
Postnatal sepsis is a well-known risk factor for developing BPD 37,58,60. However, Novotsky 
et al showed in a study of 9000 infants that treatment with antibiotics for >48 h during the 
first week of life increased the risk for BPD and endotracheal colonization of resistant gram-
negative bacteria 61. This raises a concern about prescribing routine prophylactic antibiotics 
for > 48 hours in extremely preterm infants which is common in many centers. Inflammation 
caused by supplemental oxygen, mechanical ventilation and infections increase pro-
inflammatory cytokines in tracheal aspirates and blood samples, which have been shown to 
increase the risk for BPD 62. 
1.4.4 Growth restriction 
Several studies show that being born small for gestational age (SGA) and postnatal growth 
failure is a risk factor for BPD 63-69. 
1.4.5 Persistent ductus arteriosus  
Persistent ductus arteriosus is a risk factor for BPD and death 37,70 but treatment, medically or 
surgically increases the incidence of BPD 71,72. However, late medical treatment versus early 
treatment reduces the risk for BPD 73. Surgical versus medical ligation improves survival but 
increases morbidity and worsens neurodevelopmental outcome 74. A recent review indicates 
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that if adjusting for clinical risk factors and morbidity  before ligation there is no difference in 
outcome except for lower mortality in the group with surgical ligation 75.  
1.4.6 Genetics 
There is much on-going research regarding genetic susceptibility and BPD. One twin study 
reported that genetics contributed to approximately 80% of the observed variance in rates of 
BPD 76. No genomic loci or pathways have been identified yet. The SPOCK2 gene which is 
a key regulator of alveolarization has been suggested while others suggest that angiogenesis 
related genes may be more important in the development of BPD 77,78 
 
1.5 TREATMENT STRATEGIES AND THEIR EFFECT ON BPD 
Measures to prolong pregnancy are the most efficient way to avoid BPD. If not possible, the 
lung should be protected from injury and arrested development. Increased severity of 
respiratory failure is associated with BPD and or death 42. 
1.5.1 Sustained inflation 
Sustained inflation without PEEP pressure in animal models leads to a decreased effect of 
surfactant and lung injury 79. In preterm infants there are contradictory findings regarding 
sustained inflation. There is no internationally accepted definition for sustained inflation but 
the term has been used in studies for inflation with peak inspiratory pressure of 20-25 
cmH2O for 5-15 seconds and a PEEP of about 4-6 cm H2O. Sustained inflation compared to 
standard treatment (CPAP or positive pressure intermittent ventilation) is associated with 
shorter duration of mechanical ventilation but no reduction in morbidity including BPD or 
mortality or this outcome has not been studied 80-83.  
1.5.2 Less invasive surfactant administration 
Less invasive surfactant administration (LISA) or minimally invasive surfactant therapy 
(MIST) is a technique to administer surfactant to spontaneously breathing preterm infants on 
CPAP 84,85. Since the lungs of premature infants are very susceptible to ventilator-induced 
lung injury 79,86-89, LISA has been developed to avoid mechanical ventilation in preterm 
infants with RDS. The most commonly described method is intratracheal surfactant 
deposition with a thin catheter during direct laryngoscopy.  
LISA reduces need for intubation and MV 90 and compared to INSURE (Intubation surfactant 
administration extubation) reduces MV and BPD 91. A meta-analysis has shown that LISA 
reduces BPD, BPD/death and the need for MV 92. Comparing LISA to CPAP alone, 
INSURE, nasal intermittent positive pressure ventilation, nebulized surfactant administration 
via laryngeal mask and MV, LISA was associated with less BPD/death and severe IVH and 
was found to be the best strategy in extremely preterm born infants 93. 
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1.5.3 Mechanical ventilation 
There is no consensus about optimal respiratory support for extreme preterm infants or term 
infants with lung hypoplasia.  
In a Cochrane review with 629 infants comparing volume-targeted mechanical ventilation 
versus pressure-limited mechanical ventilation BPD/ death, pneumothorax, days with 
mechanical ventilation, hypocarbia and PVL/IVH grade 3-4 were reduced 94. Synchronized 
mechanical ventilation reduces air leak and duration of mechanical ventilation but has not yet 
proven to decrease the incidence of BPD 95.  
High frequency oscillatory ventilation (HFOV) is a ventilatory strategy that in theory can be 
used to avoid volutrauma caused by conventional ventilation. HFOV used with an open lung 
strategy will enable a more uniform lung inflation and better alveolar/ saccular recruitment. 
Animal studies demonstrate that HFOV gives less lung injury and improves pulmonary 
outcomes, compared to conventional mechanical ventilation 96,97.  
Sun et al. showed that elective high frequency oscillatory ventilation compared to 
conventional ventilation in preterm infants reduces the rate of BPD/death, need for 
Surfactant, duration of mechanical ventilation, ROP>2 and moderate and severe neurological 
disability at 18 months 98. In this study though, Surfactant was only given to infants with 
severe RDS with PaO2/FIO2 < 200 mm Hg after 2 hours of ventilation and only to infants 
whose parents agreed to pay. 
In the last Cochrane review from 2015 comparing HFOV and conventional ventilation they 
concluded that the risk for BPD, severe ROP, cerebral paresis and poor mental development 
was decreased but risk for pneumothorax or emphysema was increased in the HFOV group 
99-102. The studies included were not consistent. All but one study showed a significant 
reduction in oxygen need at 28 or 30 days. Some used a strict lung volume recruitment 
strategy targeting at very low level of supplemental oxygen while others had a higher or 
unspecified FiO2 target 103. Adolescent survivors who had been treated with HFOV in 
infancy had superior small airway function measured with pulmonary function testing and 
higher ratings from teachers when compared to infants treated with conventional ventilation 
104.  
It has been shown that an earlier first extubation attempt leads to a shorter length of stay and 
less risk for BPD regardless if the infant required re-intubation 105. Total duration of 
mechanical ventilation was more predictive of BPD than courses of mechanical ventilation 
106. 
1.5.4 Hypocapnia 
Hypocapnia as an indicator of more aggressive respiratory management has been suggested 
as a risk factor for BPD. In one study patients with pCO2<5.3 kPa at 48 h age were more 
likely to develop BPD than infants with pCO2>6.6 kPa and in another study infants with 
hypocapnia before Surfactant treatment were more likely to develop BPD 107,108. Hypocapnia 
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will lead to a respiratory alkalosis and induces cerebral vasoconstriction with decreased 
oxygen delivery within the brain and increases neuronal excitability. It increases the risk for 
periventricular leukomalacia possibly because of hypo perfusion. When the partial pressure 
of pCO2 normalizes the vasodilatation and increased perfusion might increase the risk of 
intraventricular hemorrhage 109. 
In the lung hypocapnia induces bronchospasm, increases pulmonary-capillary permeability 
and decreases lung compliance and might affect surfactant function, which results in 
increased airway resistance and increased work of breathing. Alveolar hypocapnia also 
attenuates vasoconstriction caused by hypoxia 110.  
 
1.5.5 Hypercapnia 
Hypercapnia has been suggested to reduce ventilator-induced injury and BPD 111. Permissive 
hypercapnia during the first weeks of life to avoid intubation and enable earlier extubation 
seems to reduce BPD 46. However, permissive hypercapnia in mechanically ventilated 
extreme preterm infants has not been proven to reduce the rate of moderate/ severe BPD or 
death 112,113. Some studies even suggests that hypercapnia during mechanical ventilation 
increases the rate of BPD 114. In another study hypercapnia was also correlated to higher 
incidence of mortality, moderate/ severe BPD, NEC and a poorer neurodevelopmental 
outcome but after adjusting for respiratory index: mean airway pressure x fraction inspired 
oxygen (MAPxFiO2) and birth weight it was no longer significant. The authors conclude that 
hypercapnia might be a marker for disease severity 115. In some studies permissive 
hypercapnia seems to be lung protective and safe but the clinical benefits are modest 111. 
Other studies indicate that higher and fluctuating values of pCO2 are an independent 
predictor of IVH/death, BPD/death and NDI/death in extreme preterm infants 116. The last 
Cochrane review performed in 2001 did not find enough evidence to recommend permissive 
hypercapnia 113. Nevertheless, marginal increase in pCO2 level from 6.4 kPa (48 mmHg) to 
6.93 kPa (52 mmHg) leads to a significant reduction in days on mechanical ventilation 117,118.  
In an animal study though, hypercapnic acidosis increased pulmonary pressure even after 
normalizing the pH value with buffer 119. In vitro models show that alveolar fluid clearance 
and repair of epithelial cell membranes in the lung are impaired by hypercapnia 120,121. 
Hypercapnia reduced functional vessel density in the skin at two weeks of age with fewer 
small vessels but more large vessels 122. Direct effects of hypercapnia within the lung in 
infants have not been studied. 
1.5.6 Fluid and nutrition 
Higher volumes of fluid and less weight loss during the first 10 days of life are risk factors for 
developing BPD 37 but so is poor postnatal growth. A balance must be achieved to provide 
enough calories without fluid overload. 180 ml/kg/day of standard formula compared to 145 
ml/kg/day concentrated formula from 28 days of age in infants with BPD did not reduce 
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oxygen requirement at 36 weeks postmenstrual age 123. Fluid restriction is controversial and 
adequate nutritional intake must be taken into consideration.  
Furosemide improve short term respiratory function and might be considered to enable 
extubation or avoid reintubation but has no effect on long term pulmonary function or 
incidence or severity grade of BPD 124,125.  
Early nutrition is essential. Malnutrition increases incidence and severity grade of BPD 69. A 
minimum of 2 grams protein/kilo and 2 gram of lipids/kilo should be given the first day with 
an increase to 3.4-4.0 grams/kg/day within 72 hours 126. Energy needs for infants with BPD 
are 15-25% higher than in infants without BPD. A daily energy intake of 140-150 
kcal/kg/day is recommended 127. Early excess weight gain must be avoided thought since this 
increase the risk for later insulin resistance and metabolic disease 128.  
1.5.7 Pharmacological interventions 
1.5.7.1 Vitamin A 
Intramuscular injection of vitamin A three times a week reduces BPD/ death with 7% 129. In 
animal models vitamin A or retinoid acid attenuates lung injury and alveolar simplification 
and promotes alveolarization 130. It has not been widespread clinically because of modest 
effect and the risk and discomfort of multiple intramuscular injections. 
1.5.7.2 Steroids 
Steroids have been used to reduce inflammation and induce lung maturation but have side 
effects. Steroids alter weight gain velocity with a decrease during and after treatment and a 
later catch-up during the first two years of life. Head circumference growth is delayed but 
normalized at one year of age in boys but not normalized in girls 131. In animal models it 
reduces alveolar surface area 130. Follow-up studies have shown increased risk of 
neurodevelopmental impairment at two years of age 132, especially cerebral palsy 133, and 
decreased brain volume in adolescence 134. After reports like these the use of postnatal 
systemic steroids in very low birth weight infants decreased from around 20% per year 1997-
2000 to about 8% presently in the US.  
More recent reviews showed a decreased risk for BPD and improved neurodevelopmental 
outcome for infants receiving high cumulative doses of Dexamethasone (> 4 mg/kg) 
compared to infants receiving moderate doses (2-4 mg/kg) or low doses (<2 mg/kg). Early 
administration (started <8 days of age) compared to moderately early (started at 8-21 days of 
age) or delayed (started >21 days of age) did not alter outcome of BDP, death or BPD or later 
neurodevelopmental impairment 135 In a Cochrane review from 2017 they conclude that 
compared to placebo, early systemic steroids (before 8 days of age) decreased rate of 
BPD/death or BPD at 28 days and 36 weeks postmenstrual age. It improved 
neurodevelopmental outcome at 2 years of age in some studies but not in others. Steroids 
reduced the incidence of patent ducts arteriosus and ROP but had short-term adverse effects 
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with increased risk for gastrointestinal perforation, hyperglycemia, hypertension, 
hypertrophic cardiomyopathy and growth failure 136.  
Late steroid treatment (started after 7 days of age) reduced BPD at 28 days and 36 weeks 
postmenstrual age without increasing neurological impairment at late follow-up 137. It reduces 
mortality at 28 days but not at 36 weeks postmenstrual age. It decreases death/BPD at both 28 
days and 36 weeks. There is a trend for increase in infections and gastrointestinal bleeding 
but not in NEC and a trend for reduction in severe IVH. There was also an increase in severe 
ROP but not blindness. There was no substantial difference in neurological outcome or 
respiratory health and function at two years of age but later in childhood a significant 
decrease in FEV1 in the Dexamethasone group 137.  
In the PREMILOC study 523 infants were given a low dose of Hydrocortisone for the first 10 
days of life, total dose 8.5 mg/kg. This increased the rate of survival without BPD at 36 
weeks postmenstrual age and had no adverse effect on neurodevelopmental outcome at 22 
months of corrected age 138,139. Another study with early but 30% higher doses of 
hydrocortisone showed that at 5-7 years of age 61% of the children in the hydrocortisone 
group had some neurodevelopmental impairment but only 39% in the placebo group. This 
study included 18 cases and 19 controls at follow-up 140. 
Inhaled corticosteroids starting before seven days of age have been shown to decrease BPD 
or death at 36 weeks postmenstrual age 141. There was no difference in neurodevelopmental 
outcome at two years of age but an increase in mortality in the budesonide group 142. Inhaled 
corticosteroids started after seven days of age increased probability of successful extubation 
but there was no difference in rate of BPD, mortality or days with mechanical ventilation 143. 
There is one promising study showing that installation of budesonide together with surfactant 
reduces additional doses of surfactant needed and incidence of BPD or death/BPD. Levels of 
interleukins in tracheal aspirate were also lower than in infants only receiving surfactant. No 
adverse effects including differences in neurodevelopmental outcome at 2 years of age were 
noted. In this study though, up to six doses of surfactant and budesonide were given 144. 
1.5.7.3 Bronchodilators 
Salbutamol increases short-term lung mechanics but there is no reduction in BPD or mortality 
145,146. One small study showed a significant reduction of oxygen dependency and BPD in 
infants treated with aminophylline the first 10 days of life 147. The quality of evidence in this 
study was graded as very low. 
1.5.7.4 Nitric oxide 
Inhalation of nitric oxide has no proven effect in premature infants with or without 
pulmonary hypoplasia as rescue treatment, prevention or treatment for incidence of BPD or 
BPD/death 148-150.  
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1.5.7.5 Caffeine 
Caffeine was initially used for prevention of apnea of prematurity but several studies have 
shown that it also increases the rate of successful extubations, decreases days with MV, 
reduces the rate of BPD and improves neurodevelopmental outcome at 1, 2 and 5 years of age 
151-155. There is some evidence that a higher maintenance dose reduces the incidence of BPD 
or death/BPD and improves neurodevelopmental outcome but these results must be verified 
in a larger study before a general recommendation can be given 156. 
1.6 COMPLICATIONS OF BPD 
BPD increases the risk for growth failure, pulmonary hypertension, neurodevelopmental 
delay, hearing defects and retinopathy of prematurity 157. Rehospitalization because of 
respiratory symptoms is common the first two years of life 158. Children with BPD have lower 
IQ, more academic difficulties and delayed speech and language development compared to 
preterm children without BPD 159. 
 
1.7 LONG-TERM LUNG FUNCTION  
Children with BPD often report persistent respiratory problems at school age and in adult life 
6,160. Lung function in these children and adults is usually evaluated with pulmonary function 
testing (PFT) or reported symptoms only. PFT mainly measures small airway function while 
New BPD affects the distal unit with reduced alveolar surface and altered vascularization. 
However, children with BPD have a sustained impairment in lung function, measured with 
conventional pulmonary lung function testing (PFT), during childhood and adolescence 161-
165.  
Longitudinal studies in one cohort of children show little improvement in pulmonary function 
testing between 2 and 8 years of age suggesting an irreversible early airway-remodeling 
process 166. Other studies though indicate that alveolarization can continue up to adult age 5. 
Studies in adult survivors of preterm birth demonstrate that they have a capillary rarefaction 
167. How this is related to vascularization and ventilation perfusion matching within the lung 
is unknown. Figure 7 is a summary of studies illustrating the difference between FEV1 values 
in survivors with BPD and normal controls at different ages. 
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Figure 7. 6 FEV1% in preterm born survivors of BPD in childhood, adolescent and young 
adulthood compared with full term born individuals at the same age. 
Copyright © 2007 Massachusetts Medical Society. Reprinted with permission from 
Massachusetts Medical Society. Baraldi E, Filippone M. N Engl J Med 2007;357:1946-1955. 
In healthy subject lung function increases until the age of around 25 years of age. Then it 
progressively decreases. In preterm born survivors the maximum capacity measured with 
spirometry will be less and in preterm born survivors with BPD the plateau will be even 
lower 162. In smokers the deterioration will be faster than in healthy persons. Little is known 
about the deterioration rate in preterm born survivors with and without BPD. Data from a 
large cohort of patients with very low birth weight indicates that lung function in subjects 
with BPD may be deteriorating at a more rapid rate than in low birth weight subjects without 
BPD and compared to reference values 163. Figure 8 shows a theoretical model of 
development of FEV1 in individuals with BPD and healthy subjects according to age. The 
dashed lines represent the potential effect of smoking. 
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Figure 8 6 Theoretical development of FEV1 in individuals with BPD compared to healthy 
individuals according to age 
 
Copyright © 2007 Massachusetts Medical Society. Reprinted with permission from 
Massachusetts Medical Society. Baraldi E, Filippone M. N Engl J Med 2007;357:1946-1955. 
1.8 IMAGING TECHNIQUES AND EVALUATION OF LUNG FUNCTION IN 
INFANTS AND CHILDREN WITH BPD 
It is difficult to evaluate lung function in infants. Chest X-ray, CT scan and conventional 
magnetic resonance imaging (MRI) examination provides an anatomical image but gives no 
information about actual lung function. Functional MRI has been used in experimental 
settings in children but not infants. Pulmonary function tests in infants are investigator 
dependent and therefore not appropriate for standardized grading of BPD.  
1.8.1 Chest X-ray 
Chest X-ray is easily accessible and is used for clinical evaluation on a day-to-day basis for 
acute complications of BPD such as edema, atelectasis, hyperinflation and lobar emphysema. 
However it gives only marginal information about severity of BPD since many patients with 
new BPD have almost normal chest X-rays despite significant respiratory symptom 168. 
1.8.2 Computerized tomography 
Several studies using High Resolution Computerized Tomography have demonstrated 
structural pulmonary abnormalities in preschool children, older children and young adults 
with BPD 169-173. The clinical implication of these abnormalities is unknown. The high 
radiation dose is also a concern. It has not been used in infants for systematic evaluation. 
These studies support the notion that BPD is a disease of the peripheral airways with arrested 
development and alveolar simplification and has limited central airway involvement 170,174. 
Some studies using CT show a correlation with BPD grade, days with mechanical ventilation 
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and pulmonary function testing but serial studies with CT is not an option because of 
increased risk for cancer 175. 
1.8.3 Conventional Magnetic resonance imaging. 
MRI has the advantage of no radiation. The major drawback of conventional MRI is that 
imaging of the neonatal lung is difficult since proton density is low and motion artifacts from 
rapid cardiac and respiratory motion degrade quality of the image. The equipment is large and 
expensive and each examination takes a long time. MRI in infants is feasible, preferably with 
a smaller specially designed MRI camera 176,177. Structural abnormalities on MRI at term age 
graded according to an MRI severity score was correlated with clinical BPD grading and 
predictive of respiratory support at discharge178. Infants with BPD have higher proton density 
than term controls but the clinical implication of this is unclear since muscle mass and fat 
composition might differ between preterm and term infants and differentiation of causes to 
high signaling is impossible. Fibrosis and atelectasis can give the same signal but have 
different implications for future pulmonary function. Long-term follow-up has not been 
reported yet. 
1.8.4 Functional MRI 
For adults and children with cystic fibrosis several experimental MRI techniques have been 
described including contrast with gadolinium chelate, magnetic “tagging” of inflowing blood, 
ultra-short echo time using 100% oxygen to map ventilation and blood flow to map 
perfusion, hyperpolarized MRI using 3He or 129Xe to image ventilation, diffusion and in some 
cases the dissolving phase in the alveoli-capillary membrane. Patient cooperation and breath 
holding maneuvers are required in most cases 179-183. These are promising techniques but 
further work need to be done regarding reproducibility and clinical significance before MRI 
can become a part of routine clinical care. Hyperpolarized gas MRI is not clinically available 
due to limited access, high costs and regulations regarding noble gases. Polarizers for noble 
gases are only available at a few specialized centers. In a review Fain states that the 
hyperpolarized MRI techniques, reported for the first time about 30 years ago, need to 
become more quantitative, sensitive and accessible to justify their current cost and 
complexity 184. 
1.8.5 Non-invasive measurement of reduced ventilation: perfusion ratio 
A non-invasive method of V/Q and shunt estimation has been developed using arterial 
oxygen saturation (SpO2) and partial pressure of inspired oxygen (PIO2) measurements with 
the normal hemoglobin dissociation curve as the reference point. Using this method Quine et 
al have stated that V/Q mismatch is the predominant cause of gas exchange impairment in 
infants with BPD 185. This method has not been validated to V/Q scintigraphy yet. 
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1.8.6 Spirometry 
Spirometry mainly evaluates small airway function while BPD is a disease of the distal 
respiratory units, with abnormal alveolar and vascular development 26. Spirometry is also 
difficult to perform and interpret in unstable infants and investigator dependent. 
1.8.7 Multi inert gas elimination technique 
MIGET is the golden standard for measuring ventilation perfusion matching 186. It is a 
complicated procedure and not clinically available. Six different inert gases are infused and 
later measured in blood and expired breath. A pulmonary artery catheter, arterial line and a 
venous line are required and measurement of expired gases. In healthy individuals, children 
and adults, the normal lung physiology studied with MIGET shows a log-normal V/Q ratio 
distribution centered around 1 with SD 0.4 and minimal V/Q mismatch 186,187. 
1.8.8 Ventilation and perfusion Scintegraphy 
The ratio of ventilation to blood flow is an important determinant for regional gas exchange 
in the lung. The first studies using radioactive gas, 133Xenon, were performed by Knipping in 
Germany in 1955 to evaluate lung function in patients with lung cancer 188. Taplin et al 
developed macro aggregated albumin particles labeled with I131 to measure regional 
pulmonary blood flow and Wagner applied perfusion scanning to the diagnosis of pulmonary 
embolism 189,190. In adult medicine ventilation/perfusion scanning is mainly used for the 
diagnosis of pulmonary embolism but other areas for diagnostic use are developing.  
V/Q relationships in BPD are not widely studied in the literature. Moylan and Shannon used 
133Xenon intravenously in 1979 to map perfusion and ventilation in four regions of the lung in 
eight BPD patients with lobar hyperinflation who could not be weaned from mechanical 
ventilation. Ventilation was measured by clearance of intravenously administered 133Xenon 
why it was actually the combined capillary alveolar diffusion and the ventilation that was 
measured. 133Xenon has a half-life of 1 minute, which limits time for registration and hence 
gives a low resolution. They concluded that ventilation was reduced in the affected lobe but 
not perfusion with severe V/Q mismatch as a result. They suggested that there was a lack of 
reflexive vasoconstriction in the poorly ventilated areas. One explanation might be that the 
infants received 40% oxygen during the examination. High levels of oxygen might aggravate 
V/Q mismatch 191. Murray et al report V/Q scans in three infants with BPD and lobar 
hyperinflation. They came to another conclusion. Ventilation was mapped with 81mKr. All 
had normal ventilation in the affected lobe, some perfusion but severe V/Q mismatch in other 
collapsed regions of the lung 192. 81mKr is a gas with a half-life of only 13 seconds, which 
gives a low resolution and requires patient cooperation for image optimization, which might 
have influenced the results. Soler et al showed a good correlation between clinical severity 
score, roentgenographic scoring 23 and two-dimensional perfusion scintigraphy at 6 months of 
age in infants with BPD compared to controls 193. 
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Planar perfusion and ventilation scans have also been used in children with congenital 
malformation to evaluate lung function before lobectomy and in follow up studies in patients 
with congenital diaphragmatic hernia 194-197. In individuals with CDH perfusion and 
ventilation in the ipsilateral lung compared to the contralateral lung are reduced during 
infancy 194,195. Ventilation gradually normalizes in the majority of the patients during 
childhood but there is a sustained reduction in perfusion 194-197 and a resulting V/Q mismatch 
198. It has been suggested that all CDH patients should be followed with planar V/Q scans 
since in some patients severe and progressive V/Q mismatch, especially on the vascular side, 
develops with increasing age 199. V/Q mismatch itself has also been demonstrated to be a 
sensitive predictor of future pulmonary morbidities such as obstructive pulmonary disease 
196,198. In cystic fibrosis skewness in V/Q matching between different parts of the lung 
correlated with FEV1 and disease severity 200.  
1.8.9 Single photon emission computed tomography  
Single photon emission computed tomography (SPECT) is a three dimensional scintegraphic 
technique that can estimates actual lung function in different parts of the lung based on 
regional ventilation (V) perfusion (P) matching. V/Q SPECT has the unique advantage of 
imaging functional changes at regional level in detail. It quantifies proportion of functional 
loss caused by matched defects (reduced ventilation and perfusion), mismatched areas 
(reduced perfusion compared to ventilation) or reversed mismatched areas (reduced 
ventilation compared to perfusion) 201. SPECT has also proven to be a sensitive method for 
detecting perfusion abnormalities within the lung in other pulmonary diseases in adults 202.  
Compared to the planar V/Q scint segmental overlap and shine-through of the adjacent lung 
is avoided and the location and size of perfusion and or ventilation defects in individual 
segments can be more accurately defined 202. SPECT has higher sensitivity, specificity and 
accuracy than planar imaging 203.  
SPECT has not been done previously in infants because of a high radiation dose, the lack of 
appropriate agent for inhalation to map ventilation and a lack of techniques for administration 
of an inhaled agent. Our new technology allows quantification of the regional distribution of 
ventilation (V) and perfusion (Q) and matching between them (V/Q match) in the lungs of 
infants with high resolution and a low radiation dose 204. To increase time for acquisition a 
Technetium-labeled aerosols with a stable deposition within the alveolar sac can be used to 
image ventilation.  
Reference values for SPECT V/Q matching for healthy individuals are difficult to find in the 
literature. Some studies have defined lung volume with V/Q ratio matching [0.8-1.2] as 
matched regions and areas outside of this range as mismatched or reverse mismatched. Others 
have defined matched regions as regions with V/Q ratio [0.6-1.4]. Combining data from our 
institution with other studies we conclude that for healthy individuals with anatomically and 
functionally normal lungs, the lung volume with good V/Q ratio matching [0.6-1.4] should 
cover more than 89% of the total lung 201,205-208. According to the current knowledge on 
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normal pulmonary physiology evaluated by multiple inert gas elimination technique 
(MIGET), the golden standard for evaluation V/Q matching, lung volume with normal V/Q 
matching should be >89% 186. V/Q ratios measured with SPECT technique are in good 
agreement with MIGET (r2=0,99) 209. 
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2 AIM 
 
The overall aim of this thesis was to complement the clinical grading of BPD with a 
functional imaging to better predict lung function morbidity during childhood and investigate 
the correlation between early respiratory strategies and later lung function impairment.  
The specific aims were: 
Paper I and II 
-To quantify the extent of lung function impairment estimated by ventilation/perfusion (V/Q) 
matching and correlate this with the current clinical severity grading for BPD and clinical 
disease severity markers for CDH.  
 
Paper I and II 
-To investigate whether V/Q abnormalities correlates with duration of respiratory support and 
need for supplemental oxygen  
 
Paper III 
-To study whether children who were diagnosed with BPD in infancy have persistent V/Q 
abnormalities at 10 years of age measured by SPECT and to correlate the abnormalities with 
clinical grading and pulmonary function testing  
 
Paper IV 
-To investigate if disease severity score and respiratory management during the first week of 
life correlates with V/Q abnormalities and clinical BPD grading at full-term  
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3 MATERIALS AND METHODS  
 
3.1 SUBJECTS AND STUDY DESIGN  
This was a cross-sectional study of preterm born subjects with BPD and subjects with 
congenital diaphragmatic hernia and suspected lung hypoplasia. All patients in study I, II and 
IV were admitted to Karolinska University Hospital between 2006-2010. Patients in study III 
were admitted to the Karolinska Hospital or Södersjukhuset in Stockholm between 1998-
1999. 
3.1.1 Paper I and IV 
The criteria for patient inclusion was a clinical diagnosis of BPD, oxygen requirement at 28 
days of age 29. Also, the infant had to be sufficiently stable to tolerate a transport to the 
Nuclear Medicine facility (5 minutes away) and to have had a recent negative 
echocardiogram excluding a right-to-left heart shunt. This was to minimize the risk of 
leakage of macro aggregate human albumin (MAA) particles to other organs. A total of 32 
infants were eligible after written and verbal parental consent. Clinical grading was 
performed at 36 weeks postmenstrual age. Three-dimensional Single photon emission 
computed tomography (SPECT) was scheduled as soon as possible after the BPD clinical 
grading was performed. Median age at SPECT was 37 weeks postmenstrual age. SPECT 
analysis data from 2 patients was excluded due to body movement artifacts. At 36 weeks all 
infants in the mild group (n=9) breathed room air with a saturation of >90%. All patients who 
required oxygen 22-30% and were free from positive pressure support failed the oxygen 
reduction test and were graded as Moderate BPD (n=11) 30,31. All patients in the severe group 
were on CPAP at 36 weeks PMA (n=10) and 5 were still on CPAP at the time of the SPECT 
investigation. There was no significant difference in PMA at examination between the 
severity groups.  
 
3.1.2 Paper II 
Twelve infants with CDH were consecutively recruited during 2006-2008. Mean GA at birth 
was 37 weeks (range 35-41 weeks). All patients underwent surgical repair of CDH in the 
newborn period. At the time of the SPECT examination the patients were on average 6 month 
of age (range 3-12 months). The hernia was left sided in 10 patients and right sided in 2 
patients. 9 of the patients had patch repair and 8 had large defects. None of the patients had 
congenital heart defects or chromosomal abnormalities. 6 patients required ECMO and 8 
infants had pulmonary artery hypertension in the postoperative period. Two patients required 
supplemental oxygen at the time of SPECT. 6 patients had no BPD, 4 had mild BPD, and 2 
had severe BPD. 
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3.1.3 Paper III 
A hospital-based prospective register of neonates with breathing difficulties in Stockholm 
County, was used to identify children with a diagnosis of BPD. Children who were born 
between January 1998 and December 1999 were invited to participate (n=75) in the 
PrematUre follow up with Lung function Mannitol and Metacholine study (PULLM) at the 
Karolinska University Hospital. 35 children with BPD accepted to participate in the PULLM 
study out of which 30 completed all studies in PULLM and 26 of these agreed to also 
participate in the SPECT study. Of the 4 patients who declined participation in the SPECT 
study, 3 had mild BPD and 1 moderate or severe BPD. Out of the 26 children who 
participated, 10 were graded as mild BPD in infancy, 10 as moderate and 6 as severe BPD 
respectively. The mean age at examination was 10.1 years (SD 0.96 years). All children 
attended regular schools and had no asthma symptoms at the time of the SPECT examination. 
There were no significant differences in GA, sex, grade of BPD, days with mechanical 
ventilation, days with CPAP, days with supplemental oxygen and APGAR score at five 
minutes between the excluded and included patients.  
 
3.2 METHODS 
 
  
Method for imaging 
infants with 3-D SPECT 
made possible by: 
Higher resolution 
Lower dose isotope needed 
Ventilation:  
99mTc-Technegas- ultra-fine 
aerosol with stable particle 
deposition within alveolar sacs 
Passive inhalation with nCPAP 
–no patient cooperation needed 
Perfusion mapped with 99mTc 
marked Albumin 
 
Examination performed in quiet sleep. 
Patient immobilized in a vacuum 
mattress 
 
 
 
februari 21, 2019 
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3.2.1 Single photon emission computed tomography 
3.2.1.1 Examination 
The SPECT examinations were performed at the Department of nuclear medicine, Karolinska 
University Hospital following the protocol previously described by our group 204. A three-
headed gamma camera (TRIAD XLT, Trionix Research laboratory, Twinsburg, OH, United 
States) equipped with low-energy, high-resolution parallel-hole collimators was used. SPECT 
acquisitions were performed with 90 projections, 30 sec per projection (15 min total 
acquisition time) and 128x128 image matrix size with a pixel size of 3.56 mm2. Perfusion 
SPECT scan was performed after intravenous administration of approximately 3-8 Mega-
Becquerel (MBq) of Technetium 99m labeled macro aggregate albumin (Tc99m-MAA; 
Mallinckrodt Medical, Petten, The Netherlands) according to age and weight. Thereafter, 
with the subject lying in the same position, the ventilation SPECT scan was started after 
administration of approximately 5-15 MBq of Technegas aerosol (Tetley Manufacturing Ltd. 
Sydney, Australia) according to age and weight during normal tidal breathing. Oxygen 
saturation and heart rate were continuously monitored with a pulse oximeter during the entire 
procedure. The contribution from Tc99m-MAA in the ventilation scan was removed by pixel 
wise subtraction in the projection plane. An ordered subset expectation maximization 
(OSEM) reconstruction algorithm with 8 subsets was used for image reconstruction of the 
perfusion, ventilation and combined SPECT projection data. Subsequently three sets of 
reconstructed transversal slices were produced. The patient received an estimated total dose 
of 0.7-1.5 mille-Sievert. 
3.2.1.2 SPECT image quantification and data analysis   
SPECT image quantification was performed using specially developed software for data 
analysis (Matlab and Image Processing Toolbox Release R2015a, The MathWorks, Inc., 
Natick, Massachusetts, United States). For each patient, the lung volume was first segmented 
using the combined ventilation perfusion reconstructed images. This ensured that all 
functional lung tissue was considered. Image lung segmentation was then performed with a 
region-growing algorithm with a seed located at the center of the lungs. Thereafter, the V and 
Q images were normalized to their average and the pixel-wise ventilation perfusion ratios 
(V/Q ratios) calculated. V /Q mismatch was used to quantify the extent of lung function 
impairment.  
V/Q ratio interval [0.6-1.4] was defined as a matched V/Q ratio. The presence of regionally 
reduced ventilation and/or perfusion matching was assessed outside of this V/Q ratio interval 
and described as mismatched if V/Q >1.4 (Q <<V) or reverse mismatched if V/Q < 0.6 
(V<<Q). The extent of these three V/Q functional regions was expressed as a percentage of 
the total lung volume and scored for each patient at a BPD group level. In preterm infants we 
divided the group in two according to SPECT findings. V/Q matching in less than 50% of the 
lung volume was defined as unsatisfactory SPECT and V/Q matching in more than 50% of 
the lung was defined as satisfactory SPECT. This value was set very low based on findings 
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that all very premature infants, even ones without BPD, have a reduced lung function 19. In 
infants with CDH we compared the ipsilateral lung (the same side as the hernia), with the 
contralateral lung (opposite side) as this had been done earlier in studies with planar 
ventilation perfusion scintegraphy. Infants where the lung volume of the ipsilateral lung 
(Voli) was less than 50% of the contralateral lung (Volc) were compare with infants with Voli 
/Volc>0.5. In 10-year-old children with BPD the V/Q ratios were also re-sampled into 50 
equally spaced log V/Q ratio compartments to be able to compare to MIGET. Fractional 
distribution of V and Q 0.1-1, 1-10 and >10 was also scored.  
3.2.2 Clinical records 
Clinical parameters for all patients including gestational age, birth weight, premature rupture 
of membranes, APGAR score, SGA, days on MV, CPAP and supplemental oxygen were 
collected. Also details for postnatal age at intubation and surfactant administration, uneven 
distribution of surfactant and daily, for the first seven days of life, values for pCO2 
maximum, minimum and fluctuations, MAP, FiO2, days with MV the first week of life, 
oxygenation index and CRIB score (clinical risk index for babies) were collected for 
premature infants with BPD. Days with ECMO and persistence of pulmonary hypertension 
were recorded for infants with CDH. Pulmonary function test findings, medication for asthma 
and result on Asthma Control Test were recorded for children born preterm with BPD.  
 
3.3 STATISTICAL ANALYSIS 
In paper I the statistical analysis was performed using MATLAB. Student’s t-test was used 
for continuous measures. Regression was used to identify predictors of V/Q abnormalities. A 
correlation for gestational age was applied.  
In paper II the SPECT data was compared between the right and left lung using non-
parametric Wilcoxon matched-pairs signed-ranks test. Student’s t-test was used for 
continuous measures when comparing groups. Regression was used to identify predictors 
regarding the variance in outcome.  
In paper III the Kruskal Wallis test, Mann-Whitney U test and Student’s t-test were used for 
continuous measures where appropriate. 
In paper IV the Kruskal Wallis test and Mann-Whitney U tests were used where appropriate 
to compare BPD groups, clinical parameters and V/Q matching. The material was normally 
distributed except for oxygenation index so parametric methods could have been used in all 
statistical calculation like we did in paper I but due to the small sample size and many 
parameters analyzed we decided to also use non-parametric tests. Linear Mixed Model was 
used for continuous repeated measures and clinical and demographic explanatory variables. 
An interaction term was introduced in the model to examine heterogeneity effect. We also 
used Generalized Estimating Equation to analyze ordinal outcome variables, to control for 
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potential confounders and to examine the fixed effect of gender. Multiple linear regression 
analysis was employed to examine the relationship and control for potential confounders for 
independent samples. For all statistical analysis, P<0.05 was considered significant. 
 
3.4 ETHICAL CONSIDERATIONS 
The regional ethical committee in Stockholm, and the radiation protection committee at 
Karolinska University Hospital approved all studies included in this thesis and written and 
verbal consent was obtained from all parents of the participating infants and children. 
Individual results of the SPECT examination were given to the parents by the investigator or 
the clinician responsible for the patient. The examination involved no discomfort for the 
subjects and no severe adverse events were reported 
.
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4 RESULTS AND DISCUSSION 
In summary all the studies reveal that infants and children with BPD or CDH have 
widespread V/Q abnormalities (Figure 1). Lung function measured with SPECT is negatively 
correlated with days on mechanical ventilation in infants but not in 10-year-old children. A 
need for supplemental oxygen at 36 weeks postmenstrual age in preterm infants and at 28 
days and 56 days of age in infants with CDH is correlated with V/Q abnormalities. In 
children there was a non-significant trend for reduced V/Q matching with increasing severity 
grade of BPD.  
 
 
 
 
Figure 1. Representative coronal SPECT slices of lung ventilation (V) and perfusion (Q), and 
corresponding ratio (V/Q) for one individual from each BPD group of preterm born infants. 
Left panel, mild BPD patient showing a good V/Q matching in both lungs. Middle panel, 
moderate BPD with more uneven V/Q matching. Right panel, severe BPD with widespread 
abnormalities in both ventilation and perfusion and low matching between the two. 
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4.1 LUNG FUNCTION 
In study I, preterm infants with BPD, only 54% (range 28%-76%) of the total lung volume 
had satisfactory V/Q matching. In study II, in infants with CDH, the V/Q matching in the 
lung on the hernia side was 38% (range not measurable-74%) and on the contralateral side 
56% (range 36%-73%). In some patients the hernia side lung received as little as 3% of total 
ventilation and perfusion. In the CDH group as a whole the ipsilateral lung contributed to 
30% of the ventilation and 28% of the perfusion. In Figure 2 three examples of distribution 
between the lungs are show. 
In preterm born children with BPD, now at school age, approximately 62% (range 46%-82%) 
of the total lung volume had good V/Q matching.  
In infants with BPD there was a left shift of the V/Q distribution curve with an increasing 
severity grade of BPD with ventilation being more affected than perfusion. In the 10-year-old 
preterm born children with BPD it was the opposite with a right shift of the curve for the 
whole group with reduced perfusion contributing more to the V/Q abnormalities. Lung 
volume with mismatch (V>Q) was larger compared to areas with revere mismatch (Q>V), 
26.2% and 11.8% respectively (Figure 3.) This was also true for some of the infants with 
CDH with very low perfusion in the ipsilateral lung.  
Expressing lung function as V to V/Q and Q to V/Q we found that in 10-year-old children 
with BPD the fractional distribution of ventilation and perfusion to V/Q was reduced 
compared to lung healthy children at the same age, V to V/Q was 31% compared to 64% 
respectively and Q to V/Q 51% compared to 89% respectively.
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Figure 2. SPECT results for three diaphragmatic hernia patients with respectively good (A), 
moderate (B), and poor (C) relative ventilation (V) and perfusion (Q) distribution between the 
hernia side lung (left) and contralateral lung. The plots to the right represent the 
corresponding lung volume histograms of V/Q ratio values in each side of the lung. The 
colored region on the plot represents the fraction of the lung volume within V/Q [0.6, 1.4].
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Figure 3. V/Q matching in 10-year-old children with BPD born preterm according to BPD 
severity group. A reference line (MIGET) indicates normal distribution of V/Q values with 
about 90% of the V/Q distribution within the marked box V/Q [0.6-1.4]186. In children with 
BPD the distribution curves are flatter with less values within normal range and the curves 
are shifted to the right with larger area under the curve for V/Q>1.4 than for V/Q<0.6 
 
4.2 SPECT AND CLINICAL GRADING/ DISEASE SEVERITY MARKER 
Lung function estimated by V/Q matching is correlated to some extent with clinical severity 
grading. In paper I we noted that infants with an increasing severity grade of BPD had an 
increasing rate of V/Q abnormalities (Figure 1). However, 3/9 infants with mild BPD and 
3/11 infants with moderate BPD had severe V/Q abnormalities with good matching in less 
than 50% of the lung. But we also noted that in the severe BPD group 4/10 had good V/Q 
matching within the lungs. 
In study II, in the CDH patients, we noted that BPD was correlated with V/Q mismatch. 
Patients without BPD had better V/Q matching both in the hernia side lung and in total lung 
volume. Lung volume with good V/Q matching in infants with no BPD was 60% in the 
contralateral lung and 61% in the ipsilateral lung. In infants with BPD the corresponding 
values were 53% in the contralateral lung and 14% in the ipsilateral lung (Figure 4).  
ECMO can also be used as a marker of disease severity of CDH. Increasing days with ECMO 
was correlated to decreasing functional lung volume measured with SPECT in the ipsilateral 
lung. 
  
Results: 
 
 
mars 4, 2019 
Results: 
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Figure 4. Lung volume with V/Q [0.6-1.4] in infants with congenital diaphragmatic hernia 
according to no BPD or BPD diagnosis. Contralateral side lung is shown on the left and 
hernia side on the right.  
Contralateral side: lung volume with good V/Q matching: No BPD: 60%, BPD: 53% 
Hernia side: lung volume with good V/Q matching: No BPD: 61%, BPD: 14% 
 
In the 10-year-old children there was a trend for decreasing lung volume with good V/Q 
matching and increasing clinical severity grade of BPD in infancy (Figure 5). This did not 
reach statistical significance in our material. 
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Figure 5. Representative SPECT image of three 10-year-old children with BPD clinically 
graded as mild (A), moderate (B) and severe BPD (C). At the bottom there is an image from a 
healthy individual (D). 
Lung volume with good V/Q matching; A: 74%, B: 63%, C: 46%, D: 88% 
 
4.3 CLINICAL CHARACTERISTICS AND V/Q 
Presence of persistent pulmonary hypertension in the postoperative period in infants with 
CDH significantly correlated with the degree V and Q abnormalities. 
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Diffusion capacity for carbon monoxide in school children with BPD had a positive linear 
correlation for lung volume with good V/Q matching. Other pulmonary function test were not 
correlated to V/Q matching. 
4.4 RESPIRATORY SUPPORT AND LUNG FUNCTION 
No correlation was seen in preterm infants with BPD and preterm born children with BPD 
between V/Q abnormalities and duration of supplemental oxygen or days with CPAP but in 
infants with CDH there was a correlation between longer duration of supplemental oxygen 
and worse function of the ipsilateral lung measured with SPECT.  
In preterm infants with BPD the lung volume with satisfactory V/Q matching was decreased 
and in infants with CDH the ipsilateral lung volume was decreased compared to the 
contralateral lung volume with increasing days with mechanical ventilation. No relationship 
between mechanical ventilation and V/Q matching was seen in the 10-year old children. 
In preterm infants with BPD we saw an association between a higher distending airway 
pressure on day 1 (11.9 cmH2O versus 8 cmH2O) and a larger decrease in MAP during the 
first week (5.6 cmH2O versus 2 cmH2O) and better V/Q matching. Higher pCO2 on day 1, 
(9.2 kPa (69mmHg) versus 7.3 kPa (55 mmHg)), and on average day 1-7 (8.4 kPa (63 
mmHg) versus 7.5 kPa (56 mmHg)) was also associated with better V/Q matching (Figure 6, 
Table 1) 
 
 
A: pCO2:day 1: 12.4 kPa, day 1-7: 8.98 kPa, MAP: day 1: 10 cmH2O, decrease day 1-7: 5 cm H2O. V/Q [0.6-1.4] 76% 
B: pCO2: day 1: 6.88 kPa, day 1-7: 8.22 kPa, MAP: day 1: 9.0 cmH2O, increase day 1-7: 0.5 cm H2O. V/Q [0.6-1.4] 32% 
Figure 6. Representative coronal SPECT slices of lung ventilation (V), perfusion (Q), and 
V/Q ratio distribution in preterm infants with different respiratory management. In B the V/Q 
curve is shifted to the left implying that ventilation is more affected than perfusion 
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Table 1. Mean airway pressure and pCO2 according to V/Q matching within the lung in 
preterm infants the first week of life 
	 Lung	volume	with	V/Q	[0.6-1.4]		
<	50%	of	the	lung	
Lung	volume	with	V/Q	[0.6-1.4]		
>	50%	of	the	lung	
MAP	day	1	(cmH2O)	 8	(4-16)	 11.9	(7-21.4)*	
Decrease	in	MAP	day	1-7(cmH2O)	 2	(5.1-increase	9.5)	 5.6	(14-increase	3.2)*	
pCO2	day	1	(kPa)	 7.3	(5.6-13.9)	 9.2	(6.4-21.4)*	
pCO2	day	1-7	(kPa)	 7.5	(5.9-9.5)	 8.4	(7.1-10.1)*	
Mechanical	ventilation	day	1		 67	%	 89	%	
Mechanical	ventilation	day	7	 75	%	 50	%	
Values are median and range *p<0.05 
4.5 RESPIRATORY SUPPORT AND BPD GRADING 
In the preterm born infants with BPD higher mean airway pressure, oxygenation index and 
fraction of inspired oxygen at the end of the first week of life were associated with increasing 
severity grade of BPD (Figure 7). More days with mechanical ventilation, both the first week 
and in total, days with CPAP and supplemental oxygen also correlated with increasing 
severity grade of BPD (Figure 7). Preterm infants with mild BPD received surfactant at a 
higher postnatal age than infants with severe BPD. 
In 10-year-old children increasing days with CPAP and supplemental oxygen was correlated 
to increasing severity grade of BPD  
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Figure 7. Top panel: Mean airway pressure day 7, Middle panel: supplemental oxygen day 7 of life, Bottom 
panel: days with mechanical ventilation first week in preterm infants according to severity grade of BPD.  
* Outlier       ** P<0.05 between Mild and Severe groups 
1=	Mild	BPD,		
2=	Moderate	BPD	
3=Severe	BPD**	
1=	Mild	BPD,		
2=	Moderate	BPD	
3=Severe	BPD**	
1=	Mild	BPD,		
2=	Moderate	BPD	
3=Severe	BPD**	
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4.6 CLINICAL CHARACTERISTICS AND MANAGEMENT 
Mean gestational age for the preterm born infants with BPD was 26.8 week (range 23-32 
weeks) and mean birth weight 976 g (range 578-1700 g). There was a significant difference 
in birth weight if two infants with hydrops fetalis were excluded between infants with mild 
and severe BPD. Infants with severe BPD received more postnatal steroids than infants with 
mild/ moderate BPD.  
There was no association between CRIB score or respiratory index the first week (mean 
MAP day 1-7 x mean FiO2 day 1-7) and V/Q matching or BPD severity grade in infants born 
preterm with BPD.  
Mean gestational age for infants with CDH was 37 weeks (range 35-41 weeks). 
Mean gestational age for the preterm born10-year-old children with BPD was 26.6 weeks 
(range 23-32 weeks).  
Lung function measurements for this group at 10 years of age have been reported earlier 210. 
They had lower forced expiratory volume during 1 second, forced vital capacity and vital 
capacity with increasing severity grade of BPD. Diffusion capacity for carbon monoxide was 
in the lower range for the group as a whole but was not correlated to severity grade of BPD. 
There was little evidence for ongoing inflammation measured by fraction of exhaled nitric 
oxide. They also scored high on the Asthma control test 211, which is used to evaluate 
respiratory symptoms in children with asthma. I high score is representative of well-
controlled asthma. 
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5 DISCUSSION  
 
The survival rates of extremely preterm born infants, and infants with congenital 
malformations associated with pulmonary hypoplasia, have increased during the last decades. 
In infants born at 24 weeks gestational age, the survival rate has increased from 25% to 75% 
in the last 30 years 1,212. Survival rate for infants with congenital diaphragmatic hernia has 
increased from 40% to 69% in the same time 10,11. Current adult survivors with BPD, preterm 
born or with congenital diaphragmatic hernia, represents a different population than the 
children surviving today. As a group, the preterm born infants were less premature and the 
patients with CDH most likely had less severe pulmonary hypoplasia. Lung function results 
in these adult survivors may not predict the lung function in today’s infants born at the limit 
of viability or surviving CDH infants. 
Why use SPECT? 
Clinical grading of BPD is a poor marker of future respiratory impairment 213. We wanted to 
find a reliable measurement of lung function to complement clinical grading. This will aid us 
in giving more comprehensive information to parents about what to expect regarding lung 
function in their child after hospital discharge. SPECT is a method well tolerated in infants 
and children and provides unique information about regional lung function, which cannot be 
obtained by any other method 204. SPECT will give a functional measurement of the lung by 
estimating the percentage of total lung volume with good matching between ventilation and 
perfusion, a prerequisite for an efficient gas exchange. SPECT in asymptomatic adult patients 
with normal lung function tests has revealed heterogeneities not revealed by the lung function 
testing and is able to sensitively predict pulmonary morbidity such as obstructive pulmonary 
disease 214. The radiation dose of SPECT is also very low, only a fraction of the yearly 
background radiation, and significantly lower than for example computed tomography, which 
makes it suitable for examinations in infants and children 204. To repeat the same functional 
imaging later in childhood can increase our knowledge about potential for development and 
repair within the lung in these children. 
Summary of the principal findings 
! Preterm infant with BPD, infants with CDH and preterm born children with BPD 
have substantial V/Q abnormalities when examined with SPECT. 
! Early respiratory management was associated with V/Q matching within the lung.  
! We report for the first time that a higher level of permissive hypercapnia during 
the first week of life may be associated with a better lung function at term.  
! A higher mean airway pressure on day one and a larger-faster reduction in MAP 
was also associated with better V/Q matching.  
! V/Q abnormalities were associated with increasing days with mechanical 
ventilation.  
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! In infants at 36-37 weeks postmenstrual age ventilation was more affected than 
perfusion but in children with BPD, reduced perfusion contributed more to the 
V/Q abnormalities.  
! The NIH definition of BPD created in 2001 based on oxygen requirement is 
correlated to V/Q mismatch in preterm infants and infants with CDH. However it 
did not identify some patients with severe V/Q abnormalities and defined other 
patients with good V/Q matching within the lungs as severe BPD.  
! Some children, in the 10-year-old group, with good values on lung function 
testing who did not report any respiratory problems or problems in participation in 
physical activities had widespread V/Q abnormalities.  
! Respiratory requirement at one week of age and days with mechanical ventilation 
the first week of life and in total were correlated to BPD severity grade.  
! Total days with supplemental oxygen was not correlated to V/Q mismatch in 
preterm subjects with BPD. 
Importance and relevance of our V/Q findings  
Infants with BPD, infants with CDH and children with BPD born preterm have substantial 
V/Q abnormalities. In preterm infants with BPD only 54% of the total lung volume had 
satisfactory V/Q matching. In infants with CDH both lungs were affected. At the same side as 
the hernia, 38% of the lung volume had good V/Q matching, and on the other side this figure 
was 56%. Hence, infants with CDH born at a higher gestational age (10 weeks on average) 
had worse lung function measured with SPECT than extremely/ very preterm born infants. In 
some patients with CDH the ipsilateral lung hardly contributed to gas exchange at all making 
these patient completely dependent on one lung. In children, diagnosed with BPD in infancy, 
62 % of the lung volume had satisfactory V/Q matching, which is still lower than in lung 
healthy children at the same age. According to the literature, lung volume with good V/Q 
matching should be around 89% 205,206,209,215.  
What is unique with our studies is that they, for the first time, demonstrate the presence of 
V/Q defects in infants with BPD and CDH and that the V/Q abnormalities persist in survivors 
with BPD. They demonstrate a functional loss in the lung that has significance for both short 
and long term health in these patients. 
Association of V/Q to early respiratory management  
Respiratory strategies and requirements were associated with V/Q abnormalities at term age. 
Hypocapnea is a known risk factor for BPD 107,108. Hypercapnia has in some studies been 
associated with increasing rates of moderate/ severe BPD 114. Other studies indicate that 
hypercapnia might be an indicator of disease severity and not a risk factor per se115. 
We are the first ones to show that higher levels of permissive hypercapnia on the first day of 
life and the first week of life might be associated with a better lung function. Higher values of 
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pCO2 were associated with less V/Q abnormalities at term age. Respiratory index was not 
correlated to V/Q matching or clinical grade of BPD. 
An open lung strategy with higher MAP to open up the lung in the beginning but early 
weaning of mechanical ventilation was also associated with better V/Q matching. Other 
studies support that early extubation is lung protective even if reintubation is needed 105,106. 
However, it seems safe to wait with surfactant since in our study infants with mild BPD 
received surfactant at a later postnatal age than infants with severe BPD. This is also in line 
with the published literature 216. Total number of days with supplemental oxygen is a poor 
marker for respiratory morbidity according to the literature. Our finding of no correlation 
between total days with supplemental oxygen and V/Q matching agrees with this. 
Repair of the lung? 
We find it promising that the lung volume with good V/Q matching seems to be higher in 
BPD children than in preterm infants with BPD. The range of lung volume with good V/Q 
matching was also narrower, 46%-82% in children with BPD compared to 28%-76% in 
preterm born infants with BPD. Hence, there were no individuals with extremely low 
matching between ventilation and perfusion among the children but this was more common 
among the infants. This could possibly point in a direction of a potential for regeneration and 
repair even in the worst cases. This is also supported by the fact that V/Q abnormalities were 
correlated with increasing days with mechanical ventilation in infants but not in children. The 
initiation of ventilation either manual or mechanical is a major risk factor for developing 
BPD 47,79. We speculate that the acute effects of volutrauma from MV are mitigated over time 
with the postnatal reparative process and continued alveolarization. We cannot be certain of 
these findings, because although similar in gestational age, the patients came from different 
cohorts. A longitudinal study in one set of patients would be of value.  
Ventilation or perfusion abnormalities?  
In preterm infants with BPD we saw a left shift of the V/Q distribution with increasing 
severity grade of BPD thus indicating that ventilation was more affected than perfusion while 
we saw the opposite in the 10-year-old children and some of the infants with CDH with the 
perfusion more affected than the ventilation. The preterm infants with BPD were examined at 
an earlier age than the infants with CDH (37 weeks postmenstrual age and 6 months 
corrected age respectively). We speculate that the preterm infants with BPD are still in the 
acute phase with ongoing inflammation and airway obstruction while the infants with CDH 
and the preterm children with BPD are in a more chronic phase of lung disease.  
Evidence of new and old BPD 
The visual appearance of the SPECT scans reveals a heterogeneous pattern of V/Q defects 
increasing in number with the increasing severity grade of BPD giving a patchy impression of 
scattered areas with poor V/Q matching. In the description of the histopathology of the “new” 
BPD, seen in the surfactant era, a more uniform disease is observed. It describes an arrested 
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alveolar development, including both airspaces and vasculature resulting in a simplification 
of the distal structure and a reduced diffusion surface area 26. This is in marked contrast to the 
descriptions of “old” BPD in the pre-surfactant era with a severely damaged lung with 
variously atelectatic or enlarged air spaces and an almost cobblestone like appearance. Are 
we seeing structural defects resembling old BPD reflected in the patchy distribution of the 
most prominent V/Q defects? An uneven surfactant distribution will often exist in more 
severe cases and this will lead to areas more susceptible to volutrauma and uneven injury 
patterns The nature of the injury could play a role as volutrauma in the surfactant deficient 
lung has been shown to be a major risk factor in the acute lung injury caused by ventilation 
217. A combined anatomic and functional investigation using CT-SPECT would be one way 
of looking at these areas more closely 
Potential for development and repair 
There is some evidence that alveolarization might have a greater potential for recovery than 
the abnormal and reduced vascularization seen in preterm born subjects with BPD 5,167,218,219. 
This has also been demonstrated in subjects with CDH. Vascular growth does not, in some 
patients, match alveolar development after the acute phase. Follow up studies to five years of 
age show that in infants with CDH ventilation is normalized to a greater extent but perfusion 
remains affected 195. Early disturbances in vascularization might not have the same potential 
for recovery. This might also be true for preterm children with BPD with the findings of a 
more reduced perfusion in our study of the 10 year-old BPD children.  
Clinical grading of BPD in relation to V/Q findings 
A concern is that the clinical oxygen and/or positive pressure criteria at 36 weeks may not 
identify important pulmonary abnormalities that can lead to a reduced lung capacity in BPD 
survivors 33,220. We found that in patients with mild BPD 33% had V/Q mismatch in more 
than 50% of the lung indicating a risk for a reduced pulmonary function in the future. The 
implication of this finding is that the severity grading used at the time of our study may miss 
patients with significantly reduced lung function and an ensuing risk that these patients may 
miss out on closer longitudinal follow-up of their lung function. The definition based on 
oxygen requirement and respiratory support has its merits though. It is easy to apply and has 
some predictive value.  
A refinement has been suggested for the definition and grading of BPD 36. It is also based on 
oxygen requirement and need for respiratory support but also includes newer modes of 
respiratory support like high flow nasal cannula. It states that a premature infant with BPD 
should have radiographic confirmation of parenchymal lung disease without specifying what 
these findings should be.  
 In infants with BPD we found that higher mean airway pressure, oxygenation index and 
higher oxygen requirement were associated with increasing severity of BPD. One week of 
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age might be a good time point to identify patients who are candidates for more alternative 
treatment or therapeutic strategies in research settings. 
 
Severity markers for congenital diaphragmatic hernia 
Presence of persistent pulmonary hypertension in the postoperative period in infants with 
CDH is strongly correlated with V and Q abnormalities. This is in line with the literature 
suggesting that persistent pulmonary hypertension is related to the degree of vascular 
hypoplasia within the lung in CDH patients. If the vascular hypoplasia is pronounced, the 
lung cannot accept the right ventricular output with a poor outcome as a result 9. Persistence 
of PPHN post-surgery is associated with decreased survival. In one report the mortality was 
100% if PPHN was sustained at 6 weeks of age 221.  
Increasing days with ECMO was also associated with V/Q abnormalities. The need for 
ECMO is a known risk for poor outcome. Survival for infants not requiring ECMO is 70-
90% while it is 50% in infants who do 222. A diagnosis of BPD was also correlated to 
increasing V/Q abnormalities. V and Q abnormalities seem to be important elements in the 
pathophysiology of CDH.  
Long-term follow-up 
Pulmonary function in children diagnosed with BPD in infancy is often evaluated by lung 
function testing or reported symptoms only. The group of 10-year-old children with BPD had 
low dynamic flow values. They had lower forced expiratory volume during 1 second, forced 
vital capacity and vital capacity with increasing severity grade of BPD and on average a 
lower diffusion capacity for carbon monoxide (DLCO) than normal. This agrees with 
findings showing longitudinal limitations in airflow in subjects with BPD and in preterm 
infants generally 162,223. Studies on infants with developing BPD in infancy have reported 
abnormalities in measured variables, especially compliance and lung volumes that correlate 
with the severity of BPD 224,225. With increasing age, the pattern of lung function 
abnormalities on traditional PFT in survivors with BPD seem to mostly reveal airflow 
limitations, while mechanics and volumes improve perhaps due to increasing alveolarization. 
In our patients the dynamic flow values were not correlated to V/Q, but we see that higher 
DLCO was correlated to better V/Q matching but not BPD grade. DLCO is partly a 
measurement of V/Q matching and function of the alveolar-capillary unit. DLCO was in the 
lower range for the group, thus confirming the residual abnormalities in lung function. 
 
Some of the children had relatively normal lung function testing values but abundant V/Q 
abnormalities. With SPECT you can discover functional abnormalities not detected by lung 
function testing 214,226 In general the children diagnosed with BPD in infancy scored high on 
Asthma control test, indicating few respiratory symptoms despite low values on dynamic 
spirometry and a reduced lung function measured with SPECT.  
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Some well appearing infants with CDH and no respiratory symptoms proved to have 
practically no lung function in on the hernia side and 10-year-old children with a history of 
BPD who reported no limitation in exercise capacity or respiratory symptoms proved to have 
substantially lower functional lung volume than lung healthy children the same age. We 
speculate that children and their parents are not aware of these abnormalities but have just 
adapted their life style accordingly. These children would probably benefit from early 
physical training to increase their lung capacity.  
 
Methodological limitations 
We did not perform a simultaneous CT scan; therefore we could not outline the borders of the 
lung anatomically, only functionally. Thus, we may have missed areas at the outer borders of 
the lung with matched V/Q defects and underestimated V/Q abnormalities.  
Even though the radiation dose for SPECT is low, a fraction of the yearly background 
radiation dose, we could not recruit an age matched control group for reference. This is due to 
ethical restrictions that were imposed by the radiation protection and ethics committees of 
Stockholm County. 
No reference values exist for V/Q SPECT in infants and children. We had to compare our 
results with healthy subjects examined at our department (children and adults), reference 
values from the literature on V/Q matching and children examined with MIGET (the golden 
standard for V/Q). Previous work shows that V/Q ratios measured with the SPECT technique 
are in good agreement with MIGET (r2=0,99) 209. In children with CDH we compared the 
ipsilateral lung with the contralateral lung and risk underestimating the abnormalities in the 
ipsilateral lung since the contralateral lung can also be affected. 
Further our sample size is small, and this introduces a risk of missing some significant 
differences.  
 
6 CONCLUSION AND REFLECTIONS 
SPECT can be used as a measurement of lung function and evaluation of treatment in 
neonatal patients, infants and children. It can also be used as a complement to clinical grading 
and for follow-up of lung function in survivors with BPD. Ventilation perfusion matching 
abnormalities are common among patients with BPD both in the newborn period and at 
school age suggesting the presence of residual alveolar-capillary impairment. 
The current definition does not identify all individuals with pulmonary abnormalities and 
should be revised to include a functional measurement of the lung.  
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Since extreme preterm born infants as a group have a reduced pulmonary function we 
recommend that all extremely preterm born infants, even subjects without BPD, should have 
an evaluation of lung function before discharge to identify patients with abnormalities and 
include these in pulmonary follow-up programs.  
We must strive to refine our early management of extremely preterm infants. Respiratory 
management the first day of life and the first week have associations with V/Q matching at 
term age. Higher values of pCO2 and an open lung strategy the first day of life with early 
weaning of mechanical ventilation were associated with better V/Q matching at term age. 
Respiratory requirement at one week of age was correlated with BPD severity grade at 36 
weeks postmenstrual age. Infants at risk at 7 days of age should be considered for inclusion in 
research studies on treatment alternatives. 
The criteria for CPAP treatment placing an infant in the severe BPD category can be 
questioned since 40% of infants with severe BPD in our study, who all had CPAP at 36 
PMA, had good V/Q matching within the lung. We welcome the refinement of grading by 
Higgins, 2018, where infants with CPAP and FiO2 <0.3 are graded as BPD I or II.  
The criteria of including radiographic findings of parenchymal lung disease at 36 PMA in the 
Higgins definition can also be questioned since infants with new BPD can have arrested 
alveolar development and reduced vascularization without radiographic abnormalities and we 
instead suggest a functional imaging to get a better evaluation of actual lung function. 
 
7 FUTURE PERSPECTIVES 
The advances in functional pulmonary imaging have opened up new possibilities of 
understanding the pathophysiology of lung function impairments in prematurely born infants. 
The diagnosis of bronchopulmonary dysplasia is based on the treatment of the disease, a 
requirement of supplemental oxygen and or respiratory support at a certain age. Within this 
group all kinds of different lung function abnormalities coexist. “Old” BPD with mechanical 
injuries, “new” BPD with arrested alveolar development and decreased vascularization, lung 
hypoplasia due to congenital abnormalities or infants small for gestational age, lung 
hypoplasia due to anhydramnios of different causes and genetically more susceptible infants. 
The lung function abnormalities will also depend on when in the developmental phase of the 
lung they occurred and what iatrogenic factors the infant is exposed to. What we know is that 
all extreme premature infants are at risk for adverse pulmonary outcome as are many of the 
more mature infants with other risk factors. 
All infants with risk factors for adverse pulmonary outcome should be followed 
longitudinally with measurements of lung function.  
Oxygen requirement at 36 weeks postmenstrual age or 56 days is a poor marker for lung 
function. Pulmonary functional testing does not fully evaluate distal pulmonary function and 
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gas exchange and is not sensitive to subtle changes in the alveolar-capillary unit. Anatomical 
imaging can give some information but does not evaluate actual lung function. 
SPECT in the newborn period, during childhood and at young adult age could enhance our 
understanding of the pathophysiology of the developing lung in these patients. How 
widespread are the ventilation and perfusion abnormalities? What is the potential for catch-up 
of developing functional alveolar-capillary units? Do the arrested alveolar development and 
the abnormal vascularization have the same potential for normalization? Is the mechanism 
similar between preterm infants with BPD and infants with congenital diaphragmatic hernia 
both with evidence of vascular hypoplasia on histological examination?  
Combining SPECT with CT in selected cases can increase resolution and correlate 
radiographic findings with lung function impairments to further enhance our understanding of 
these abnormalities. 
Further development of functional MRI to make it clinically available would be desirable as 
radiation could then be avoided completely.  
Evaluation of early treatment strategies and new therapies should be performed with a 
functional measurement and not just oxygen requirement at 36 weeks postmenstrual age since 
this gives limited information about actual lung function. 
Hopefully a new definition and grading for BPD can be developed in the near future 
including a functional measurement to predict future lung impairment. This will enable us to 
benchmark centers with different treatment strategies and evaluate new therapies. 
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8 SWEDISH SUMMARY 
Överlevnaden för extremt förtidigt födda barn och barn med medfödda missbildningar har 
ökat kraftigt de senaste 30 åren. Många av dessa barn får en nedsatt lungfunktion. Att ta hand 
om dessa individer på bästa sätt är ett stort ansvar för samhället. De ska inte bara överleva 
tiden på sjukhus utan även få en bra barndom och fungera normalt i vuxenlivet. Min 
avhandling har främst fokuserat på hur vi kan utvärdera dessa barns lungfunktion. 
Kronisk lungsjukdom hos spädbarn, även kallat bronchopulmonell dysplasi (BPD) 
(bronk=luftväg, pulm=lunga, dysplasi=sjuklig förändring i vävnad ofta som svar på yttre 
retning) beskrevs redan för 50 år sedan av William Northway. Han konstaterade att måttligt 
förtidigt födda barn, som avlidit på grund av andningssvikt, hade kraftiga avvikelser i hur 
lungvävnaden såg ut. Vissa delar av lungan var sammanfallna och andra delar alltför 
uppblåsta. Vissa lungblåsor, alveolerna, var helt stängda och vätskefyllda och andra hade 
spruckit upp. Lungvävnaden var kraftigt inflammerad med ärrbildning och avvikelser i 
lungblodkärlen. Orsaken till dessa skador var troligen respiratorbehandling med höga tryck 
som gav mekaniska skador och höga nivåer av syrgas som i sig kan ge en inflammatorisk 
reaktion. Under 90-talet skedde ett flertal genombrott inom neonatalvården som ledde till att 
fler mycket förtidigt födda barn överlevde. Dessa barn hade också ett långvarigt syrgasbehov 
men den mikroskopiska bilden i lungvävnaden såg annorlunda ut med mindre inflammation 
och mekaniska skador. Man noterade istället att den utveckling av alveoler och blodkärl som 
normalt sker den sista tredjedelen av graviditeten uteblivit eller försenats.  
Den definitionen för BPD som används mest idag är att barnet fortfarande behöver extra 
syrgas vid 28 dagars ålder. Svårighetsgradering sker då hos mycket förtidigt födda barn i 
motsvarande vecka 36 och annars vid 56 dagars ålder beroende på behov av extra syrgas eller 
annat andningsunderstöd. Vissa använder bara syrgasbehov/ behov av andningsunderstöd 
vecka 36 som definition för BPD. Bägge dessa definition har dock många brister. Behov av 
extra syrgasbehov eller andningsunderstöd behöver inte betyda att barnet har en 
underliggande lungsjukdom och alla barn med nedsatt lungfunktion kräver inte extra syrgas. 
Nästan alla barn födda före den 28:e graviditetsveckan har syrgas eller andningsstöd vid 28 
dagars ålder. Detta kan bero på ett omoget andningsmönster eller en ännu inte fullt utvecklad 
lunga och behöver inte betyda att barnet kommer att få en framtida lungfunktionsnedsättning. 
Även vecka 36 kan syrgasbehovet bero på andra faktorer såsom magbesvär, omogenhet, 
infektion eller annan tillfällig försämring. Med dessa definitioner riskerar man att missa vissa 
barn med kroniskt nedsatt lungfunktion och felaktigt identifiera andra som sjuka.  
Syftet med min avhandling var att försöka komplettera den definition som används för BPD 
idag med en funktionell undersökning av lungan för att kunna ge en prognos om risk för 
framtida lungbesvär, planera uppföljning och behandling samt identifiera eventuellt behov av 
speciellt inriktade träningsinsatser. Den funktionella lungundersökningen kan även användas 
för att utvärdera effekten av olika behandlingsstrategier och följa utvecklingen av lungan 
under barndomen och upp i vuxen ålder.  
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Det är komplicerat att undersöka lungfunktion hos spädbarn. De flesta röntgenmetoder ger 
bara en anatomisk bild av lungan utan någon information om faktisk funktion. Spirometri i 
nyföddhetsperioden är undersökarberoende och svårt att genomföra på de sjukaste patienterna 
och man kan därför sällan dra några generella slutsatser. Spirometri undersöker dessutom 
framförallt de medelstora och små luftvägarna. Hos barn med BPD är det mestadels de distala 
delarna av lungan, alveoler och lungkapillärer, som är drabbade,  
Lungans viktigaste funktion är att ta upp syre i kroppen och göra sig av med koldioxid. För 
att detta ska kunna ske så effektivt som möjligt behöver man en stor yta för diffusion av syre 
från alveolen in i kapillärerna och en lika stor yta för diffusion av koldioxid från blodet till 
den luftfyllda alveolen. En försämrad lungfunktion kan bero på stopp i de stora luftvägarna 
genom till exempel svullnad i svalget, svullnad av de små luftvägarna vid till exempel astma 
eller ett ökat avstånd mellan alveolar och kapillärer vid till exempel mekaniska eller 
inflammatoriska retningar. Den alveolära ytan kan också vara minskad till följd av emfysem 
eller avstannad/försenad utveckling vid BPD. Blodkärlen kan ha förtjockade väggar eller vara 
underutvecklade till följd av medfött diafragmabråck som har komprimerat lungvävnaden. 
Luften och blodet kan också ha en dålig matchning i lungan och inte gå till samma ställen. 
Hos förtidigt födda barn med BPD är det ofta en kombination av flera orsaker som leder till 
lungfunktionsnedsättningen men framförallt är det en störning i gasutbytet mellan alveoler 
och kapillärer. För att få en uppskattning av lungans förmåga till ett effektivt gasutbyte kan 
man undersöka hur blodet och luften fördelar sig i lungan i förhållande till varandra, om det 
är ”matchat”. Single photon emission computed tomography (SPECT) är en teknik för att 
undersöka fördelning av ventilation och blodflöde i lungan tredimensionellt. Tidigare har 
man inte kunnat göra denna undersökning på spädbarn. Genom teknisk utveckling, delvis 
utförd i vår forskargrupp, är det nu möjligt. Vi har undersökt 30 förtidigt födda barn med 
BPD i nyföddhetsperioden (studie I och IV), 12 barn med medfött diafragmabråck vid cirka 6 
månaders ålder (studie II) och 26 förtidigt födda barn med BPD som nu är cirka 10 år gamla 
(studie III) med SPECT. Vi har även tittat på behandling och sjuklighet under vårdtiden, 
svårighetsgrad av BPD och hos de 10 åriga barnen, resultat på lungfunktionsmätning med 
spirometri. 
Vi kunde konstatera att de flesta barnen hade omfattande avvikelser i matchning mellan luft 
och blodflöde i lungan. Dessa avvikelser överensstämde till viss del med 
svårighetsgraderingen av BPD. Vissa barn som fått diagnosen svår BPD hade en i stort sett 
normal matchning av luft och blodflöde i lungan. Andra som fått diagnosen mild BPD eller 
inte fått någon BPD diagnos hade grava avvikelser i lungfunktion mätt med SPECT. Vi 
noterade också att vissa barn i 10 års ålder som själva inte upplevde sig ha några lungbesvär 
eller fysiska begränsningar på grund av nedsatt lungfunktion och hade normala värden på 
spirometri hade omfattande avvikelser i matchning av luft och blod i lungan. Dessa barn har 
en hög risk för framtida lungfunktionsnedsättning och kan ha nytta av en tät uppföljning och 
tidiga insatser vid eventuell försämring.  
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Vi noterade också att ju fler dagar barnet haft i respiratorbehandling, desto sämre var 
lungfunktionen mätt med SPECT. Även i andra studier har man kunnat konstatera att förtidigt 
födda som behandlas med CPAP istället för respirator löper mindre risk att utveckla BPD. 
Våra fynd tyder på att vi bör sträva efter att minska antalet dagar med respiratorbehandling 
och försöka extubera förtidigt födda barn och barn med medfött diafragmabråck så tidigt som 
möjligt. Vi konstaterade också att förtidigt födda spädbarn som haft högre koldioxidvärden i 
blodet första veckan, så kallad ”permissiv hyperkapne”, hade bättre matchning av luft och 
blodflöde i lungan. Man har tidigare visat att onormalt låga värden av koldioxid ökar risken 
för BPD men man har inte kunnat visa att höga jämfört med normala värden minskar risken 
för BPD. Genom att tillåta högre koldioxidvärden kan man minimera tryck i respirator och 
extubera tidigare.  
Vi anser att alla extremt förtidigt födda spädbarn och spädbarn med riskfaktorer för 
lungfunktionsnedsättning bör göra en funktionell undersökning av del av lungan som kan 
förväntas vara påverkad. Detta för att tidigt identifiera barn i riskzonen. Ur ett 
samhällsperspektiv kan man även spara resurser genom att tidigt sätta in behandling vid 
försämring och därmed minska risken för återinläggningar på sjukhus vid till exempel 
luftvägsinfektioner och ge specifika tränings råd till de barn som behöver för att främja deras 
lungkapacitet i framtiden.  
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